The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis
Abstract
The renin-angiotensin-aldosterone system (RAAS) has emerged as an important hormonal system in the initiation and pathogenesis of atrial fibrillation (AF). Therefore, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are emerging as novel drugs for the prevention of AF. A meta-analysis of 11 randomized, controlled, parallel-design clinical trials evaluating effect of ACEIs or ARBs on the development of AF was performed. Treatment with ACEIs or ARBs reduced the relative risk (RR) of AF in patients with hypertension by 23% [RR 0.769, P < 0.001, 95% confidence interval (CI) 0.686-0.862] and by 11% in patients after myocardial infarction (RR 0.898, P < 0.05, 95% CI 0.814-0.992). Reduction in AF was greatest in patients after electrical cardioversion (RR 0.491, P < 0.001, 95% CI 0.334-0.720) and in patients with heart failure (RR 0.684, P < 0.001, 95% CI 0.594-0.787). Overall, inhibition of the RAAS reduced the RR of AF by 19% (RR 0.810, P < 0.001, 95% CI 0.759-0.865).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Secondary analyses of ACE inhibitors or ARBs in patients with heart failure or LVH show a lower incidence of new-onset AF.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [238]
In the citing paper
“Retrospective analyses from large randomized trials have reported a lower incidence of new-onset AF in patients treated with ACE inhibitors/ARBs compared with placebo.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [238]
Citations
Cites
Atrial Fibrillation Begets Atrial Fibrillation
WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033
Hansson, L., Lindholm, L. H., NISKANEN, L. K., Lanke, J., Hedner, T., Niklason, A., LUOMANMÄKI, K., Dahlöf, B., Fairé, U. D., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 1,991
Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & Fairé, U. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,442
The Study on Cognition and Prognosis in the Elderly (SCOPE)
Lithell, H., Hansson, L., Skoog, I. G., Elmfeldt, D., Albert Hofman, D., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,419
Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation
Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997) · Circulation · doi:10.1161/01.cir.96.4.1180 · Cited by 1,400
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,362
Promotion of Atrial Fibrillation by Heart Failure in Dogs
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343
GRUPPOITALIANOPERLOSTUDIODELL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90232-1 · Cited by 1,201
Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.068 · Cited by 826
Research works printed but not linked: 2
- Webster, 1985, Effects of enalapril on ventricular arrhythmia in congestive heart failure., Am J Cardiol, 56, 566, 10.1016/0002-9149(85)91186-5 · DOI
- van den Berg, 1995, Effects of lisinopril in patients with heart failure and chronic atrial fibrillation., J Card Fail, 1, 355, 10.1016/S1071-9164(05)80004-1 · DOI
Cited by
Sorted by citations
Items 101–112 of 112
Akioyamen, L. E., Levine, M., Sherifali, D., Frankfurter, C., Pullenayegum, E., Goeree, R. A., & Tsoi, B. (2016)
UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
Анатольевна, П. Е., Фурман, Н. В., & Reshetko, O. V. (2012) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2012-8-4-561-568
Prevention and Treatment of Atrial Fibrillation in Patients with Hypertension
Kjeldsen, S. E., Aksnes, T. A., Erdine, S. E., & Manolis, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-39599-9_9
Atrial Fibrillation and Hypertension: Two Entities That Usually Coexist
Giannitsi, S., Kallistratos, M. S., Poulimenos, L. E., & Manolis, A. J. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_17
Kuryata, O. V., Muhammad, M., & Mytrokhina, S. S. (2018) · Medicni perspektivi · doi:10.26641/2307-0404.2018.2.133695
Курята, О. В., Мухаммад, М., & Митрохіна, О. С. (2017) · Family Medicine · doi:10.30841/2307-5112.2(70).2017.115147
The Biomark of Atrial Fibrillation in Patients with Essential Hypertension: Aldosterone
Xu, J., Wang, R., Fu, M.-M., Kuang, D., Shen, L., Wei, Y. Q., Chen, S., Xiao-FengLu, Ding, Y., Zhou, G., et al. (2020) · Journal of Clinical & Experimental Cardiology
Barış, Ö., Kanko, M., Parlar, H., Yavuz, Ş., & Berki, K. T. (2020) · Kocaeli Medical Journal · doi:10.5505/ktd.2020.87369
Prevention and Treatment of the Troubles of the Elderly
Libertini, G., Corbi, G., Conti, V., Shubernetskaya, O. S., & Ferrara, N. (2021) · Advances in studies of aging and health · doi:10.1007/978-3-030-73774-0_8
Welche kardiale Diagnostik braucht Ihr Hypertoniker?: Kardiovaskuläre Gefahren aufspüren
Ukena, C., Mahfoud, F., & Böhm, M. (2014) · MMW - Fortschritte der Medizin
Hamid, A. (2013) · Otago University Research Archive (University of Otago)
Metadata
- Authors
- Jibrini, M. B., Molnar, J., & Arora, R. R.
- Affiliations
- American College of Cardiology (US)
- ORCID
- Arora, Rohit R
- Venue
- American Journal of Therapeutics
- Published
- 2008-01
- Volume
- 15
- Issue
- 1
- Pages
- 36-43
- ISSN
- 1075-2765 (ISSN-L)
- OpenAlex
- W2159776801
- Cited by
- 111
- References
- 43
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 10 · 2015: 5 · 2014: 11 · 2013: 8 · 2012: 7
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- atrial fibrillation, renin-angiotensin-aldosterone system, ACE inhibitors, angiotensin receptor blockers, atrial fibrillation prevention, hypertension, myocardial infarction, electrical cardioversion, heart failure
- MeSH terms
- Angiotensin-Converting Enzyme Inhibitors, Atrial Fibrillation, Electric Countershock, Heart Failure, Humans, Hypertension, Myocardial Infarction, Renin-Angiotensin System, Risk Factors, Randomized Controlled Trials as Topic, Angiotensin II Type 1 Receptor Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
